Simulations Plus, Inc. to Issue Quarterly Dividend of $0.06 (NASDAQ:SLP)

Simulations Plus, Inc. (NASDAQ:SLP) declared a quarterly dividend on Wednesday, April 3rd, Zacks reports. Shareholders of record on Monday, April 29th will be given a dividend of 0.06 per share by the technology company on Monday, May 6th. This represents a $0.24 annualized dividend and a yield of 0.52%. The ex-dividend date is Friday, April 26th.

Simulations Plus has a payout ratio of 29.6% meaning its dividend is sufficiently covered by earnings.

Simulations Plus Stock Up 2.2 %

NASDAQ SLP opened at $46.00 on Wednesday. The company has a fifty day moving average of $43.41 and a two-hundred day moving average of $40.91. The firm has a market capitalization of $919.54 million, a price-to-earnings ratio of 86.79 and a beta of 0.72. Simulations Plus has a 52 week low of $32.69 and a 52 week high of $52.69.

Simulations Plus (NASDAQ:SLP) last posted its quarterly earnings data on Wednesday, April 3rd. The technology company reported $0.20 EPS for the quarter, topping the consensus estimate of $0.18 by $0.02. The company had revenue of $18.31 million during the quarter, compared to analyst estimates of $17.31 million. Simulations Plus had a net margin of 16.22% and a return on equity of 7.95%. Simulations Plus’s quarterly revenue was up 16.2% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.20 earnings per share. Equities research analysts anticipate that Simulations Plus will post 0.67 EPS for the current year.

Analyst Ratings Changes

Separately, Craig Hallum lifted their price objective on shares of Simulations Plus from $50.00 to $51.00 and gave the stock a “buy” rating in a research note on Thursday, January 4th.

Insider Activity

In other news, Director Walter S. Woltosz sold 18,945 shares of the business’s stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $38.02, for a total transaction of $720,288.90. Following the completion of the sale, the director now directly owns 3,641,250 shares of the company’s stock, valued at $138,440,325. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, Director Walter S. Woltosz sold 20,000 shares of the business’s stock in a transaction dated Monday, April 1st. The shares were sold at an average price of $39.94, for a total value of $798,800.00. Following the completion of the sale, the director now owns 3,600,195 shares in the company, valued at approximately $143,791,788.30. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Walter S. Woltosz sold 18,945 shares of the business’s stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $38.02, for a total transaction of $720,288.90. Following the completion of the sale, the director now owns 3,641,250 shares of the company’s stock, valued at approximately $138,440,325. The disclosure for this sale can be found here. Insiders own 20.90% of the company’s stock.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.